# Open-Label Extension Study of ASTORIA

> **NCT05516875** · PHASE2 · TERMINATED · sponsor: **Contera Pharma A/S** · enrollment: 6 (actual)

## Conditions studied

- Dyskinesias

## Interventions

- **DRUG:** JM-010

## Key facts

- **NCT ID:** NCT05516875
- **Lead sponsor:** Contera Pharma A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2024-01-19
- **Primary completion:** 2024-05-22
- **Final completion:** 2024-06-27
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** The trial is terminated based on business decision, not due to safety concerns or regulatory requirements.
- **Last updated:** 2024-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05516875

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05516875, "Open-Label Extension Study of ASTORIA". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05516875. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*